NCT07348211 2026-01-23SIM0610-101Jiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Recruiting260 enrolled
NCT05047536 2025-12-19KZR-261 in Subjects With Advanced Solid MalignanciesKezar Life Sciences, Inc.Phase 1 Terminated61 enrolled 25 charts
NCT06948539 2025-04-29To Evaluate the Tolerability and Pharmacokinetics of TQB2101 for Injection in Patients With Advanced Malignant TumorsChia Tai Tianqing Pharmaceutical Group Co., Ltd.Phase 1 Not yet recruiting66 enrolled